| Log in

EILSF makes first close of new healthcare fund, scores third exit this year with Gland Pharma

28 November, 2013

Life sciences-focused private equity fund EILSF (Evolvence India Life Sciences Fund), which has just struck a deal with buyout giant KKR & Co to sell its stake in Gland Pharma ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
India Life Sciences Fund II backs dermatology chain Oliva

India Life Sciences Fund II backs dermatology chain Oliva

Madhav A Chanchani 4 years ago
Good looks matter to the Indian consumer, and private equity investors know it...
Evolvence Life Sciences Fund Backs Vivimed Buy With $12.5M Financing

Evolvence Life Sciences Fund Backs Vivimed Buy With $12.5M Financing

Madhav A Chanchani 6 years ago
Sector-focused private equity fund Evolvence India Life Sciences Fund has backed...
Temasek bets $25.7M in HealthCare Global; EILSF exits with 2.2x returns

Temasek bets $25.7M in HealthCare Global; EILSF exits with 2.2x returns

Lohit Jagwani 5 years ago
Singapore’s sovereign wealth fund Temasek has invested Rs 140 crore ($25.7...
No Comments

EILSF makes first close of new healthcare fund, scores third exit this year with Gland Pharma

Powered by WordPress.com VIP